Uniworth Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-05-2024
- Paid Up Capital ₹ 0.50 M
as on 17-05-2024
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2017)
- Profit 142.92%
(FY 2017)
- Ebitda 153.03%
(FY 2017)
- Net Worth 24.98%
(FY 2017)
- Total Assets 0.40%
(FY 2017)
About Uniworth Biotech
The Company is engaged in the Animal Husbandry Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Shyam Rathi, Harish Mandre, Kaushal Kumar, and One other member serve as directors at the Company.
- CIN/LLPIN
U01409WB1995PLC067266
- Company No.
067266
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
09 Jan 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Uniworth Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyam Rathi  | Director | 10-Nov-2008 | Current |
| Harish Mandre | Director | 10-Apr-2021 | Current |
| Kaushal Kumar | Director | 07-Jul-2023 | Current |
| Kamal Sharma | Director | 31-Dec-2013 | Current |
Financial Performance and Corporate Structure Insights of Uniworth Biotech.
Uniworth Biotech Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 142.92% increase in profit. The company's net worth Soared by an impressive increase of 24.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uniworth Biotech?
In 2017, Uniworth Biotech had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Uniworth International LtdActive 32 years 6 monthsHarish Mandre and Kaushal Kumar are mutual person
- Texworth Credit & Commercial Pvt LtdActive 31 years 7 months
Shyam Rathi and Harish Mandre are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Uniworth Biotech?
Unlock and access historical data on people associated with Uniworth Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uniworth Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uniworth Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.